EVOLUTION AT MERCK - INVENTING FOR LIFE
ADDRESSING TUMOR TYPES WITH HIGHEST
INCIDENCE, INCLUDING BREAST AND PROSTATE
Breast cancer market expected
to grow to $38B by 20281
⚫ TNBC represents 10-15% and ER+/HER2- represents
~65% of all breast cancers
• Program addresses different stages of disease and
lines of therapy
Prostate cancer market expected
to grow to $15B by 20281
mCRPC represents 20% and mHSPC represents 20% of
all prostate cancers
• Broadest I-O development program addressing all
stages of mCRPC and moving into mHSPC
1Representative of U.S., EU5, and Japan
Source: GLOBOCAN 2018. International Cancer Research Agency 2018
Global incidence
of top tumor types
Other
cancers
7,753,946 (42.9%)
Lung
2,093,876 (11.6%)
Breast
2,088,849 (11.6%)
MERCK
INVENTING FOR LIFE
Colorectal
1,849,518 (10.2%)
Cervical
569,847 (3.2%) Esophageal Liver
572,034 (3.2%)
Prostate
1,276,106 (7.1%)
Stomach
1,033,701 (5.7%)
841,080 (4.7%)
#
Mike Nally
61View entire presentation